This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tanaka, K. Articles by Niwa, M. Search for Related Content PubMed PubMed Citation Articles by Tanaka, K. Articles by Niwa, M.

Expression Profile of Receptor-Type Protein Tyrosine Kinase Genes in the Human Thyroid

Departments of Pharmacology 1 (K.T., Y.N., M.N.) and Nature Medicine, Atomic Bomb Disease Institute (N.T., H.N., S.Y.), Nagasaki University School of Medicine, Nagasaki 852-8523; The Shionogi Research Laboratories, Shionogi Co. (T.N.), Osaka 553; and Kuma Hospital (S.F., K.K.), Kobe 650, Japan

Address all correspondence and requests for reprints to: Yuji Nagayama, M.D., Department of Pharmacology 1, Nagasaki University School of Medicine, 1–12-4 Sakamoto, Nagasaki, 852-8523, Japan. E-mail: nagayama{at}net.nagasaki-u.ac.jp

Protein tyrosine kinases (PTKs) play a role in regulating the growth and differentiated functions of thyroid cells and are probably involved in tumorigenesis of papillary-type thyroid carcinoma. To better understand the roles of PTKs in the physiology and pathophysiology of the thyroid, we analyzed the expression profile of receptor-type PTKs in normal human thyroid tissues. Highly conserved regions in the catalytic domains of receptor-type PTKs were amplified by RT-PCR using degenerate oligonucleotide primers. Nucleotide sequencing of about 100 clones identified 21 PTKs, including 16 receptor type and 5 nonreceptor type; no novel PTK was identified. Insulin-like growth factor I receptor, platelet-derived growth factor receptor (PDGFR), TrkE, Axl, epidermal growth factor receptor, etc., appear to be the most abundant receptor-type PTKs in the thyroid; many of which (PDGFR, TrkE, Axl, etc.) have never previously been demonstrated to be expressed in the thyroid. The expression of messenger RNAs (mRNAs) for PDGFR, axl, and trkE in normal thyroid cells was confirmed by Northern blot analysis, and interestingly, the expression levels of PDGFR and trkE mRNAs were decreased in all three thyroid carcinoma cell lines examined (FRO, WRO, and NPA), whereas axl mRNA and protein were overexpressed in 2 of 3 thyroid carcinoma cell lines (FRO and WRO) compared with that in normal tissue. The axl gene was, however, neither amplified nor rearranged. The biological activity of the ligand for Axl, the product of growth arrest-specific gene 6 (Gas6), was then evaluated, demonstrating modest mitogenic activity in thyroid carcinoma cells overexpressing Axl. Furthermore, gas6 mRNA was expressed in FRO cells.

Thus, we here identify a variety of PTKs expressed in the thyroid gland, many of which may participate in the regulation of thyroid cell function. Variable expression levels of some PTKs in normal and cancerous cells suggest that there may be an imbalance and disarray of phosphorylation events in thyroid carcinoma cells. Furthermore, Gas6 is identified as a novel growth factor for thyroid carcinoma cells overexpressing Axl receptor tyrosine kinase.

This article has been cited by other articles:

				Y.-M. Wu, D. R. Robinson, and H.-J. Kung Signal Pathways in Up-regulation of Chemokines by Tyrosine Kinase MER/NYK in Prostate Cancer Cells Cancer Res., October 15, 2004; 64(20): 7311 - 7320. [Abstract] [Full Text] [PDF]

				W.S. Sun, J. Fujimoto, and T. Tamaya Clinical implications of coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine leiomyoma Mol. Hum. Reprod., November 1, 2003; 9(11): 701 - 707. [Abstract] [Full Text] [PDF]

				F. Meric, W.-P. Lee, A. Sahin, H. Zhang, H.-J. Kung, and M.-C. Hung Expression Profile of Tyrosine Kinases in Breast Cancer Clin. Cancer Res., February 1, 2002; 8(2): 361 - 367. [Abstract] [Full Text] [PDF]

				K. O'Donnell, I. C. Harkes, L. Dougherty, and I. P. Wicks Expression of Receptor Tyrosine Kinase Axl and its Ligand Gas6 in Rheumatoid Arthritis : Evidence for a Novel Endothelial Cell Survival Pathway Am. J. Pathol., April 1, 1999; 154(4): 1171 - 1180. [Abstract] [Full Text] [PDF]

				H. Yoshimoto, H. Ishihara, A. Ohtsuru, K. Akino, R. Murakami, H. Kuroda, H. Namba, M. Ito, T. Fujii, and S. Yamashita Overexpression of Insulin-Like Growth Factor-1 (IGF-I) Receptor and the Invasiveness of Cultured Keloid Fibroblasts Am. J. Pathol., March 1, 1999; 154(3): 883 - 889. [Abstract] [Full Text] [PDF]

				M.-M. Georgescu, K. H. Kirsch, T. Shishido, C. Zong, and H. Hanafusa Biological Effects of c-Mer Receptor Tyrosine Kinase in Hematopoietic Cells Depend on the Grb2 Binding Site in the Receptor and Activation of NF-kappa B Mol. Cell. Biol., February 1, 1999; 19(2): 1171 - 1181. [Abstract] [Full Text] [PDF]

				Y. Nagayama, H. Namba, N. Yokoyama, S. Yamashita, and M. Niwa Role of Asparagine-linked Oligosaccharides in Protein Folding, Membrane Targeting, and Thyrotropin and Autoantibody Binding of the Human Thyrotropin Receptor J. Biol. Chem., December 11, 1998; 273(50): 33423 - 33428. [Abstract] [Full Text] [PDF]